1. 12 - 18 months time RHY will put their hands out for more money
2. Not one Colostat kit will be sold, anywhere. Not UK, not Europe, not US and obviously not Aus
3. The TGA application will remain unsubmitted. Heaven knows why, how long does it take to prepare blank documents?
4. The share price may move a little with each announcment, given the size of its drop, BUT the market is well aware of the bullshit this company thrives on and any movement will minimal and not be sustained.
5. Competition for Colostat will only INCREASE as more labs tool up with DNA testing equipment as it becomes mandatory if the lab wants to remain viable. DNA testing costs will fall. And given the vastly superior results from DNA testing Colostat will never get a foothold anywhere.
6. RHY management will continue travelling to conferences throughout the world, on your generous dollar, to bark their credentials to people who were clearly not interested before and are even less interested now.
7. There will be no take over offer for a company with ONE test, the full results of which have not been released, are way worse than DNA testing, miserably failed their TGA application and have never sold a single kit in 3 years.
RHY Price at posting:
9.9¢ Sentiment: Sell Disclosure: Not Held
